BIOR
Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
$0.22
+0.00% today
Updated 2026-04-30
Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$0 – $0
Volume
—
Biora Therapeutics Inc (BIOR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.22
12-Month target
$0.22
2030 Target
—
Intrinsic (DCF)
$0.82
Financial forecast
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.61x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.